Larimar Therapeutics Inc (LRMR)
2.06 -0.08 (-3.95%) 12:18 ET [NASDAQ]
2.06 x 416 2.07 x 5
Realtime by (Cboe BZX)
2.06 x 416 2.07 x 5
Realtime 2.15 unch (-0.03%) 08:56 ET
for Tue, Apr 1st, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 33,218 | 35,067 | 32,311 | 110,125 | 26,749 |
| Marketable Securities | 150,236 | 168,640 | 193,753 | 117,171 | 60,041 |
| TOTAL | $195,304 | $213,256 | $231,130 | $230,953 | $90,175 |
| Non-Current Assets | |||||
| PPE Net | 881 | 779 | 844 | 604 | 684 |
| Investments And Advances | 0 | 0 | 0 | 11,711 | 0 |
| Other Non-Current Assets | 4,040 | 4,986 | 5,188 | 4,937 | 5,076 |
| TOTAL | $4,921 | $5,765 | $6,032 | $17,252 | $5,760 |
| Total Assets | $200,225 | $219,021 | $237,162 | $248,205 | $95,935 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,424 | 1,686 | 2,917 | 1,918 | 1,283 |
| Accrued Expenses | 20,872 | 13,573 | 17,246 | 10,098 | 7,386 |
| TOTAL | $24,356 | $16,285 | $21,155 | $12,841 | $9,506 |
| Non-Current Liabilities | |||||
| aiOther Non-Current Liabilities | 4,057 | 4,336 | 4,603 | 4,520 | 4,709 |
| TOTAL | $4,057 | $4,336 | $4,603 | $4,520 | $4,709 |
| Total Liabilities | $28,413 | $20,621 | $25,758 | $17,361 | $14,215 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 64,028 | 63,807 | 63,807 | 63,802 | 63,800 |
| Common Shares | 64 | 64 | 64 | 64 | 43 |
| Retained earnings | -269,158 | -240,334 | -224,835 | -203,208 | -188,554 |
| Other shareholders' equity | 148 | 358 | -150 | -25 | 81 |
| TOTAL | $171,812 | $198,400 | $211,404 | $230,844 | $81,720 |
| Total Liabilities And Equity | $200,225 | $219,021 | $237,162 | $248,205 | $95,935 |